江湖电竞官方手机版
BVS
AU
0.055
3.68%
Closed
$ 1.550
| Previous Close |
|---|
| $1.495 |
Volume: 449.73K
65 Day Avg: 912.71K
1.485
Day Range
1.560
1.345
52 Week Range
3.350
Overview
BVS Overview
Key Data
- Open $1.500
- Day Range 1.485 - 1.560
- 52 Week Range 1.345 - 3.350
- Market Cap $371.29M
- Shares Outstanding 248.35M
- Public Float 243.99M
- Beta 1.00
- Rev. per Employee $176.95K
- P/E Ratio 12.93
- EPS $0.120
- Yield 4.45%
- Dividend $0.032
- Ex-Dividend Date Sep 2, 2022
- Short Interest N/A
- % of Float Shorted N/A
- Average Volume 912.71K
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings
8
Full Ratings
SV Health Investors, LLC Cuts Portfolio Down to Size in 2nd Quarter
SV Health Investors, LLC Cuts Portfolio Down to Size in 2nd Quarter
on GuruFocus.com
Aerie Pharmaceuticals (AERI) Reports Q2 Loss, Tops Revenue Estimates
Aerie (AERI) delivered earnings and revenue surprises of 38.46% and 2.59%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
on Zacks.com
Implied Volatility Surging for Bioventus (BVS) Stock Options
Investors need to pay close attention to Bioventus (BVS) stock based on the movements in the options market lately.
on Zacks.com
ChemoCentryx (CCXI) Reports Q4 Loss, Lags Revenue Estimates
ChemoCentryx (CCXI) delivered earnings and revenue surprises of -1.75% and 33.67%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
on Zacks.com
Ardelyx (ARDX) Reports Q4 Loss, Misses Revenue Estimates
Ardelyx (ARDX) delivered earnings and revenue surprises of -24% and 48.55%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
on Zacks.com
Juniper Investment Company, LLC Buys Bioventus Inc, Lincoln Educational Services Corp, Sells , ...
Juniper Investment Company, LLC Buys Bioventus Inc, Lincoln Educational Services Corp, Sells , Universal Technical Institute Inc
on GuruFocus.com
SV Health Investors, LLC Buys Bioventus Inc, Sells , Bicycle Therapeutics PLC, Deciphera ...
SV Health Investors, LLC Buys Bioventus Inc, Sells , Bicycle Therapeutics PLC, Deciphera Pharmaceuticals Inc
on GuruFocus.com
Tamarack Advisers, LP Buys Tenet Healthcare Corp, Humana Inc, Biomarin Pharmaceutical Inc, ...
Tamarack Advisers, LP Buys Tenet Healthcare Corp, Humana Inc, Biomarin Pharmaceutical Inc, Sells Henry Schein Inc, Patterson Inc, Perrigo Co PLC
on GuruFocus.com
Chuck Royce's Firm Buys Louisiana-Pacific, Boosts H&R Block Stake
Chuck Royce's Firm Buys Louisiana-Pacific, Boosts H&R Block Stake
on GuruFocus.com
PolarityTE (PTE) Gets FDA Nod to Begin Pivotal Ulcer Study
PolarityTE (PTE) announces removal of clinical hold on a proposed pivotal study to evaluate its SkinTE for chronic cutaneous ulcers. PolarityTE plans to start enrollment in the next few months.
on Zacks.com
Cornercap Group Of Funds Buys Alpha Metallurgical Resources Inc, Exelixis Inc, APA Corp, Sells ...
Cornercap Group Of Funds Buys Alpha Metallurgical Resources Inc, Exelixis Inc, APA Corp, Sells Apogee Enterprises Inc, Meredith Corp, Carriage Services Inc
on GuruFocus.com
Affinity Investment Advisors, Llc Buys Robert Half International Inc, SM Energy Co, Halozyme ...
Affinity Investment Advisors, Llc Buys Robert Half International Inc, SM Energy Co, Halozyme Therapeutics Inc, Sells Akamai Technologies Inc, eBay Inc, Axos Financial Inc
on GuruFocus.com
3 Small Biotech Stocks in Focus on World Arthritis Day
Here we discuss three drugs or biotech companies with promising candidates in their pipeline for Arthritis indications.
on Zacks.com
Concert (CNCE) Initiates Second Phase III Hair Loss Study
Concert Pharmaceuticals (CNCE) is developing its lead pipeline candidate, CTP-543, for treating alopecia areata. Two late-stage studies are evaluating the candidate in AA patients to support a potential NDA filing.
on Zacks.com
Will Bioventus (BVS) Continue to Surge Higher?
As of late, it has definitely been a great time to be an investor of Bioventus (BVS).
on Zacks.com
Bravura Solutions Ltd.
Bravura Solutions Ltd. engages in developing software solutions. Its activities include development and distribution of software solutions and related technology. It operates through the Wealth Management and Funds Administration segments. The Wealth Management segment specializes in financial products and investment advice relating to investment products and wrap platforms, superannuation, pension and retirement products, life insurance, private wealth, and portfolio administration. The Funds Administration segment includes mutual funds, unit trusts, investment trusts, open ended investment companies, money market funds and exchange-traded funds. The company was founded by Simon Kenneth Woodfull and Iain Maxwell Dunstan on December 9, 2004 and is headquartered in Sydney, Australia.
Competitors
| Name | Chg % | Market Cap |
|---|---|---|
| Planet Technology Corp. |
|
NT$4.94B |
| Gamania Digital Entertainment Co. Ltd. |
|
NT$11.31B |
| China Communications Media Group Co. Ltd. |
|
NT$365.95M |
| Securitag Assembly Group Co. Ltd. |
|
NT$3.86B |